|
|||||
|
|
Successful management of lung adenocarcinoma with ALK/EGFR co-alterations and PD-L1 over-expression by bevacizumab combined with chemotherapy |
|
| Authors: | He Hengqiu Yang Wendi Huang Yusheng Zhang Xiaoyue Peng Yuan Yang Zhenzhou |
| Abstract: | Angiogenesis - Anaplastic lymphoma kinase (ALK)/epidermal growth factor receptor (EGFR) co-alterations in adenocarcinomas are rare and no therapeutic consensus is reached. The potentially negative... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |